NSC |
Compound |
Enrichment |
Correlation |
NSC 676368 |
5-Pyrimidinecarboxaldehyde, 2-amino-4-chloro- 6-[[[1-(hydroxymethyl)-3-(1-methylethyl)- 1-cyclobutyl]methyl]amino]- |
0.0027236921521653 |
0.315196 |
NSC 698280 |
Null |
0.0027236921521653 |
0.51185298 |
NSC 660636 |
2-[1-(4-(4'-acetophenone)piperazino)]-naphthazarin |
0.00286159651545682 |
0.18639441 |
NSC 695590 |
Null |
0.00286159651545688 |
0.14480401 |
NSC 77039 |
Null |
0.00286159651545688 |
0.13675516 |
NSC 717563 |
Null |
0.00293992674122318 |
-0.22208151 |
NSC 697747 |
9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(3-methoxyphenyl)- |
0.00293992674122322 |
0.3898643 |
NSC 651841 |
Null |
0.00322389497932883 |
0.10605957 |
NSC 174121 |
Methotrexate Derivative |
0.0038671642008129 |
0.23995936 |
NSC 677942 |
L-Glutamamide, N(2)-[4-[[(2,4-diamino-6-pteridinyl)methyl](methyl)amino]benzoyl]-N(1),N(5)-didecyl- |
0.00386716420081295 |
0.39706672 |